Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5354472 | 0.97 | ADORA3 (0.41) | ADORA3PRMT6ADORA2AADORA1P2RY12 | |
| SCHEMBL7873199 | 0.92 | PRMT6 (0.40) | ADORA3PRMT6ADORA2AADORA1P2RY12 | |
| SCHEMBL888001 | 0.91 | ADORA3 (0.45) | ADORA3ADORA2AADORA1P2RY12 | |
| SCHEMBL2112346 | 0.89 | ADORA3 (0.43) | ADORA3ADORA2AADORA1P2RY12PAX8 | |
| SCHEMBL2112012 | 0.87 | ADORA3 (0.43) | ADORA3PRMT6P2RY12 | |
| SCHEMBL439195 | 0.87 | PRMT5 (0.45) | ADORA3ADORA2AP2RY12 | |
| SCHEMBL9773291 | 0.86 | ADORA3 (0.40) | ADORA3ADORA2AADORA1PAX8 | |
| SCHEMBL15954504 | 0.86 | TYMP (0.38) | ADORA3ADORA1PAX8 | |
| SCHEMBL7523809 | 0.85 | PRMT5 (0.45) | ADORA3ADORA2AP2RY12 | |
| SCHEMBL9015823 | 0.85 | ADORA1 (0.44) | ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2952587-B1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | STRATOS GENOMICS INC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-20180334729-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | Roche Sequencing Solutions, Inc. | 2018-11-22 | — | — | US | disclosed |
| US-9920386-B2 | High throughput nucleic acid sequencing by expansion | STRATOS GENOMICS, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-20160208344-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | Roche Sequencing Solutions, Inc. | 2016-07-21 | — | — | US | disclosed |
| EP-2952587-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | Stratos Genomics Inc. (US) | 2015-12-09 | — | — | EP | disclosed |
| EP-2171088-B1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | STRATOS GENOMICS INC (US) | 2015-10-14 | — | — | EP | disclosed |
| US-20130172197-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | STRATOS GENOMICS, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| US-8431366-B2 | Modified oligonucleotides and applications thereof | APPLIED BIOSYSTEMS, LLC (US) | 2013-04-30 | — | — | US | disclosed |
| US-8349565-B2 | High throughput nucleic acid sequencing by expansion | STRATOS GENOMICS, INC. (US) | 2013-01-08 | — | — | US | disclosed |
| US-8324360-B2 | High throughput nucleic acid sequencing by expansion | STRATOS GENOMICS, INC. (US) | 2012-12-04 | — | — | US | disclosed |
| EP-0633890-B1 | SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS | ZENECA LTD (GB) | 1998-09-09 | — | — | EP | disclosed |
| EP-0305201-B1 | Protected biotin derivatives | ZENECA LTD (GB) | 1996-12-04 | — | — | EP | disclosed |
| US-5470967-A | Hybridization probes to detect nucleic acid sequences | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-11-28 | — | — | US | disclosed |
| EP-0517796-B1 | OLIGONUCLEOTIDE ANALOGS | DU PONT MERCK PHARMA (US) | 1995-04-19 | — | — | EP | disclosed |
| EP-0633890-A1 | SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS | ZENECA LIMITED (GB) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993020091-A1 | SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS | ZENECA LIMITED (GB) | 1993-10-14 | — | — | WO | disclosed |
| EP-0517796-A1 | OLIGONUCLEOTIDE ANALOGS. | DU PONT (US) | 1992-12-16 | — | — | EP | disclosed |
| WO-1991015500-A1 | OLIGONUCLEOTIDE ANALOGS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-17 | — | — | WO | disclosed |
| EP-0202758-B1 | HYBRIDIZATION METHOD AND PROBES THEREFOR | Zeneca Limited (GB) | 1991-09-25 | — | — | EP | disclosed |
| EP-0145486-A2 | Microbiological process | GLAXO GROUP LIMITED (GB) | 1985-06-19 | — | — | EP | disclosed |